* Avian myotubes: highly contractile skeletal myotubes cultured and differentiated in vitro on collagen-coated culture plates
* Cultured Meat (CM): cultured, cell based, lab grown, in vitro, clean meat obtained through cellular agriculture
* Human Bio-Artificial Muscle (BAM): formed through a seven day, in vitro tissue engineering procedure in which human myoblasts fuse and differentiate into aligned myofibres in an extracellular matrix; these constructs are used for intramuscular drug injection to replace pre- or non-clinical injection models and complement animal studies
* Myoblast transfer in the treatment of Duchenne's Muscular Dystrophy (DMD): an in vivo technique to replace dystrophin, a skeletal muscle protein which is deficient in patients with DMD; myoblasts fuse with muscle fibers and contribute their nuclei which then replace deficient gene products in the host nuclei
* Autologous hematopoetic stem cell transplantation (AHSCT) as a method for treating Multiple Sclerosis (MS): an in vivo technique for treating MS in which the immune system is destroyed and is reconstituted with hematopoetic stem cells; has been shown to reduce the effects of MS for 4-5 years in 70-80% of patients
* Volumetric muscle loss repair using Muscle Derived Stem Cells (MDSCs): an in situ technique for muscle loss repair in which patients have suffered from trauma or combat injuries; MDSCs cast in an in situ fibrin gel were capable of forming new myofibres that became engrafted in a muscle defect that was created by a partial-thickness wedge resection in the tibialis anterior muscle of laboratory mice
* Development of skeletal muscle organoids to model neuromuscular disorders and muscular dystrophies; an in vitro technique in which human pluripotent stem cells (hPSCs) are differentiated into functional 3D human skeletal muscle organoid (hSkMOs); hPSCs were guided towards the paraxial mesodermal lineage which then gives rise to myogenic pregenitor cells and myoblasts in well plates with no scaffold; organoids were round, uniformly sized, and exhibited homogeneous morphology upon full development and were shown to successfully model muscle development and regeneration
* Bioprinted Tibialis Anterior (TA) Muscle in Rats: an in vitro technique in which bioengineered skeletal muscle tissue composed of human primary muscle pregenitor cells (hMPCs) was fabricated – upon implantation, the bioprinted material reached 82% functional recovery in rodent models of the TA muscle